Approval · Notice of Compliance 33782 · 2024
ETOMIDATE INJECTION USP: Notice of Compliance 33782
Issued August 8, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33782
- Date
- August 8, 2024
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of a primary container closure system
- Canadian reference product
- TOMVI (Sterimax Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ETOMIDATE INJECTION USP | Not yet assigned | — |
Medicinal ingredients
- ETOMIDATE 2 MG per ML